By Shaun Brown
And Eric Pierce
Staff writers

The long-beleaguered U.K. biotech sector enjoyed a period of spring-like weather, as investors flocked to the group for a second week, buoyed by two strong partnering deals. The BioCentury London Index added 8 percent, bringing the sector's two-week gain to 14 percent.